BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7829272)

  • 1. Vaccination of rabbits with recombinant vaccinia virus carrying the envelope gene of human T-cell lymphotropic virus type I.
    Hakoda E; Machida H; Tanaka Y; Morishita N; Sawada T; Shida H; Hoshino H; Miyoshi I
    Int J Cancer; 1995 Feb; 60(4):567-70. PubMed ID: 7829272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term persistence of protective immunity in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the human T cell leukaemia virus type I envelope gene.
    Ibuki K; Funahashi SI; Yamamoto H; Nakamura M; Igarashi T; Miura T; Ido E; Hayami M; Shida H
    J Gen Virol; 1997 Jan; 78 ( Pt 1)():147-52. PubMed ID: 9010298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene.
    Shida H; Hinuma Y; Hatanaka M; Morita M; Kidokoro M; Suzuki K; Maruyama T; Takahashi-Nishimaki F; Sugimoto M; Kitamura R
    J Virol; 1988 Dec; 62(12):4474-80. PubMed ID: 3184271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and immunogenicity in rats of recombinant adenovirus 5 DNA plasmids and vaccinia virus containing the HTLV-I env gene.
    Kazanji M; Bomford R; Bessereau JL; Schulz T; de Thé G
    Int J Cancer; 1997 Apr; 71(2):300-7. PubMed ID: 9139857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly attenuated HTLV type Ienv poxvirus vaccines induce protection against a cell-associated HTLV type I challenge in rabbits.
    Franchini G; Tartaglia J; Markham P; Benson J; Fullen J; Wills M; Arp J; Dekaban G; Paoletti E; Gallo RC
    AIDS Res Hum Retroviruses; 1995 Feb; 11(2):307-13. PubMed ID: 7742044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An HTLV-1 envelope mRNA vaccine is immunogenic and protective in New Zealand rabbits.
    Tu JJ; King E; Maksimova V; Smith S; Macias R; Cheng X; Vegesna T; Yu L; Ratner L; Green PL; Niewiesk S; Richner JM; Panfil AR
    J Virol; 2024 Feb; 98(2):e0162323. PubMed ID: 38193692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis against a Melanesian variant of human T-lymphotropic virus type I (HTLV-I) in rabbits using HTLV-I immune globulin from asymptomatically infected Japanese carriers.
    Tanaka Y; Ishii K; Sawada T; Ohtsuki Y; Hoshino H; Yanagihara R; Miyoshi I
    Blood; 1993 Dec; 82(12):3664-7. PubMed ID: 8260703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of rabbits against HTLV-II infection with a synthetic peptide corresponding to HTLV-II neutralization region.
    Kariya N; Hayashi K; Hoshino H; Tanaka Y; Koirala TR; Ohara N; Miyamoto K; Akagi T
    Arch Virol; 1996; 141(3-4):471-80. PubMed ID: 8645089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of neutralizing antibodies against human T-cell leukemia virus type 1 using a cell-free infection system and polymerase chain reaction.
    Haraguchi Y; Yang DW; Handa A; Shimizu N; Tanaka Y; Hoshino H
    Int J Cancer; 1994 Nov; 59(3):416-21. PubMed ID: 7927951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of human T cell lymphotropic virus type I infection in Japanese macaques by passive immunization.
    Murata N; Hakoda E; Machida H; Ikezoe T; Sawada T; Hoshino H; Miyoshi I
    Leukemia; 1996 Dec; 10(12):1971-4. PubMed ID: 8946939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.
    Palker TJ; Riggs ER; Spragion DE; Muir AJ; Scearce RM; Randall RR; McAdams MW; McKnight A; Clapham PR; Weiss RA
    J Virol; 1992 Oct; 66(10):5879-89. PubMed ID: 1326649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a B-cell immunodominant epitope of human T-lymphotropic virus type 1 (HTLV-I) envelope gp46.
    Lairmore MD; Rudolph DL; Roberts BD; Dezzutti CS; Lal RB
    Cancer Lett; 1992 Sep; 66(1):11-20. PubMed ID: 1360328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a HTLV-1 subunit vaccine in prevention of experimental STLV-I infection in Macaca nemestrina.
    Dezzutti CS; Frazier DE; Lafrado LJ; Olsen RG
    J Med Primatol; 1990; 19(3-4):305-16. PubMed ID: 2172541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing antibody to vesicular stomatitis virus (HTLV-I) pseudotype in infants born to seropositive mothers.
    Iwahara Y; Sawada T; Taguchi H; Hoshino H; Umemoto M; Take H; Foung S; Miyoshi I
    Jpn J Cancer Res; 1993 Feb; 84(2):114-6. PubMed ID: 8385083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo.
    Bartoe JT; Albrecht B; Collins ND; Robek MD; Ratner L; Green PL; Lairmore MD
    J Virol; 2000 Feb; 74(3):1094-100. PubMed ID: 10627519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.
    Tanaka Y; Zeng L; Shiraki H; Shida H; Tozawa H
    J Immunol; 1991 Jul; 147(1):354-60. PubMed ID: 1711082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and protective efficacy of recombinant human T-cell leukemia/lymphoma virus type 1 NYVAC and naked DNA vaccine candidates in squirrel monkeys (Saimiri sciureus).
    Kazanji M; Tartaglia J; Franchini G; de Thoisy B; Talarmin A; Contamin H; Gessain A; de Thé G
    J Virol; 2001 Jul; 75(13):5939-48. PubMed ID: 11390595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent infection of rabbits with HTLV-I: patterns of anti-viral antibody reactivity and detection of virus by gene amplification.
    Cockerell GL; Lairmore M; De B; Rovnak J; Hartley TM; Miyoshi I
    Int J Cancer; 1990 Jan; 45(1):127-30. PubMed ID: 2353950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM; Remesar M; del Pozo A; Sen L
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin prophylaxis against milkborne transmission of human T cell leukemia virus type I in rabbits.
    Sawada T; Iwahara Y; Ishii K; Taguchi H; Hoshino H; Miyoshi I
    J Infect Dis; 1991 Dec; 164(6):1193-6. PubMed ID: 1955718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.